MII VS Onkologie Systemische Therapie Art - MII IG Kerndatensatz-Modul Onkologie v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

ValueSet: MII VS Onkologie Systemische Therapie Art

Official URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-systemische-therapie-art				Version: 2027.0.0-ballot.1
Active as of 2026-09-15				Computable Name: MII_VS_Onko_Systemische_Therapie_Art

oBDS-spezifisches ValueSet für Klassifikation der Art der systemischen oder abwartenden Therapie

References

MII PR Onkologie Systemische Therapie

Logical Definition (CLD)

Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet

Include these codes as defined in https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ version 📦2027.0.0-ballot.1

Code	Display
CH	Chemotherapie
HO	Hormontherapie
IM	Immun-/Antikörpertherapie
ZS	zielgerichtete Substanzen
SZ	Stammzelltransplantation (inklusive Knochenmarktransplantation)
CI	Chemo- + Immun-/Antikörpertherapie
CZ	Chemotherapie + zielgerichtete Substanzen
CIZ	Chemo- + Immun-/Antikörpertherapie + zielgerichtete Substanzen
IZ	Immun-/Antikörpertherapie + zielgerichtete Substanzen
WW	Watchful Waiting
AS	Active Surveillance
WS	Wait and see
SO	Sonstiges

Expansion

Expansion performed internally based on codesystem MII CS Onko Therapie Typ v2027.0.0-ballot.1 (CodeSystem)

This value set contains 13 concepts

System	Code	Display (en)	JSON	XML
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	CH	Chemotherapie
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	HO	Hormontherapie
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	IM	Immun-/Antikörpertherapie
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	ZS	zielgerichtete Substanzen
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	SZ	Stammzelltransplantation (inklusive Knochenmarktransplantation)
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	CI	Chemo- + Immun-/Antikörpertherapie
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	CZ	Chemotherapie + zielgerichtete Substanzen
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	CIZ	Chemo- + Immun-/Antikörpertherapie + zielgerichtete Substanzen
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	IZ	Immun-/Antikörpertherapie + zielgerichtete Substanzen
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	WW	Watchful Waiting
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	AS	Active Surveillance
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	WS	Wait and see
`https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ`	SO	Sonstiges

Description of the above table(s).

IG © 2022+ Medizininformatik Initiative. Package de.medizininformatikinitiative.kerndatensatz.onkologie#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-15
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.